May 7, 2025 11:37 AM EDT

Charles River launches ‘strategic review’ alongside activist investor Elliott

Anna Brown

News Reporter

Charles River Laboratories is set to start a strategic review and add four new board members after it settled on a “cooperation agreement” with Elliott …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Charles River launches ‘strategic review’ alongside activist investor Elliott

Anna Brown

News Reporter

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

Lantheus culls late-stage Lilly-partnered prostate cancer radioligand

From deal to disaster: Drugmakers face a changed Washington as Trump embraces ‘most favored nation’ prices

Teva plans staff cuts as it commits to accelerating growth

Gilead reveals plans to put another $11B into US manufacturing

Biotech stocks plunge and industry figures left to wonder after Prasad's FDA appointment

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges

Charles Riv­er launch­es ‘strate­gic re­view’ along­side ac­tivist in­vestor El­liott

News Reporter

Sign up to read this article for free.

Celldex Therapeutics

Hampton, NJ, USA

Charles River launches ‘strategic review’ alongside activist investor Elliott